Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Phase 2/3 Active not recruiting 50 enrolled The First People's Hospital of Changzhou

Non-randomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether combining of radiofrequency ablation (RFA) and cytokine-induced killer cells (CIK) transfusion can prolong survival of patients with cholangiocarcinoma.

Timeline

Start: 2012-07
Primary completion: 2030-07
Completion: 2033-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CIK cells	Cell therapy	—	Intravenous

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Summary

Timeline

Drugs

Indications